Estadístiques de Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study
Visites totals
| views | |
|---|---|
| Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study | 94 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| link-scc-effi.pdf(legacy) | 55 |
| link-scc-effi.pdf | 52 |
Vistes principals per país
| views | |
|---|---|
| United States | 67 |
| Ireland | 6 |
| Sweden | 5 |
| Italy | 3 |
| France | 2 |
| Thailand | 2 |
| South Africa | 2 |
| Australia | 1 |
| Brazil | 1 |
| China | 1 |
| Spain | 1 |
| Indonesia | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 22 |
| Boardman | 7 |
| Ann Arbor | 6 |
| Menlo Park | 6 |
| Fairfield | 5 |
| Mountain View | 5 |
| Dublin | 4 |
| Cambridge | 2 |
| Johannesburg | 2 |
| Austin | 1 |
| Cupertino | 1 |
| Jakarta | 1 |
| Redwood City | 1 |
| San Diego | 1 |
| Shah Alam | 1 |
| Shenzhen | 1 |
| São Paulo | 1 |
| Vigo | 1 |